CIK 2011932
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 77.08% | 33 |
| Health Care Providers & Services | 6.69% | 2 |
| Health Care Equipment & Supplies | 6.49% | 5 |
| Insurance | 4.58% | 2 |
| Unclassified | 3.24% | 2 |
| Life Sciences Tools & Services | 1.93% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | PRAX | Praxis Precision Medicines, Inc. | Health Care | 8.62% |
| 2 | COGT | Cogent Biosciences, Inc. | Health Care | 6.31% |
| 3 | ELVN | Enliven Therapeutics, Inc. | Health Care | 5.08% |
| 4 | IONS | IONIS PHARMACEUTICALS INC | Health Care | 4.86% |
| 5 | GH | Guardant Health, Inc. | Health Care | 4.50% |
| 6 | CYTK | CYTOKINETICS INC | Health Care | 4.02% |
| 7 | LLY | ELI LILLY & Co | Health Care | 3.79% |
| 8 | ALMS | ALUMIS INC. | Health Care | 3.62% |
| 9 | BBIO | BridgeBio Pharma, Inc. | Health Care | 2.95% |
| 10 | VERA | Vera Therapeutics, Inc. | Health Care | 2.72% |
43/45 names classified · sector 96.8% of weight · industry 96.8% · mkt cap 94.2%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 96.8% of the book is sector-classified (unclassified names shown, never dropped).
Only 17% of book weight classified — the grid is NOT representative of the whole book.
Classified: 17.3% of book weight (8/44 names) · unclassified 82.7%: PRAX, COGT, ELVN, IONS, GH, CYTK, ALMS, , BBIO, VERA +26 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | PRAXPRAXIS PRECISION MEDICINES I | 45,469 | $15M | 8.6% | TRIM −22% |
| 2 | COGTCOGENT BIOSCIENCES INC | 278,533 | $11M | 6.3% | TRIM −9% |
| 3 | ELVNENLIVEN THERAPEUTICS INC | 220,091 | $9M | 5.1% | HOLD |
| 4 | IONSIONIS PHARMACEUTICALS INC | 110,064 | $8M | 4.9% | TRIM −6% |
| 5 | GHGUARDANT HEALTH INC | 82,736 | $8M | 4.5% | TRIM −16% |
| 6 | CYTKCYTOKINETICS INC | 103,718 | $7M | 4.0% | TRIM −17% |
| 7 | LLYELI LILLY & CO | 7,012 | $6M | 3.8% | TRIM −11% |
| 8 | ALMSALUMIS INC | 279,176 | $6M | 3.6% | TRIM −4% |
| 9 | BBIOBRIDGEBIO PHARMA INC | 67,492 | $5M | 2.9% | TRIM −16% |
| 10 | VERAVERA THERAPEUTICS INC | 114,991 | $5M | 2.7% | TRIM −8% |
| 11 | INSMINSMED INC | 26,651 | $4M | 2.6% | NEW |
| 12 | ELVELEVANCE HEALTH INC FORMERLY | 14,677 | $4M | 2.5% | TRIM −15% |
| 13 | AGIOAGIOS PHARMACEUTICALS INC | 125,060 | $4M | 2.5% | TRIM −9% |
| 14 | UTHRUnited Therapeutics Corp. | 7,053 | $4M | 2.5% | TRIM −8% |
| 15 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 215,376 | $4M | 2.4% | NEW |
| 16 | NTRANATERA INC | 18,650 | $4M | 2.2% | HOLD |
| 17 | RYTMRHYTHM PHARMACEUTICALS INC | 40,581 | $4M | 2.1% | NEW |
| 18 | UNHUNITEDHEALTH GROUP INC | 12,862 | $3M | 2.0% | ADD 120% |
| 19 | APELLIS PHARMACEUTICALS INC | 85,517 | $3M | 2.0% | TRIM −37% |
| 20 | VSTMVERASTEM INC | 636,700 | $3M | 2.0% | ADD 58% |
| 21 | TXG10X GENOMICS INC | 154,194 | $3M | 1.9% | TRIM −6% |
| 22 | BSXBOSTON SCIENTIFIC CORP | 48,347 | $3M | 1.8% | NEW |
| 23 | ALKSALKERMES PLC | 84,103 | $3M | 1.7% | NEW |
| 24 | GLUEMONTE ROSA THERAPEUTICS INC | 179,484 | $3M | 1.7% | NEW |
| 25 | ISRGINTUITIVE SURGICAL INC | 6,358 | $3M | 1.7% | HOLD |
| 26 | ADAGADAGENE INC | 736,845 | $3M | 1.7% | TRIM −31% |
| 27 | ARWRARROWHEAD PHARMACEUTICALS IN | 45,721 | $3M | 1.7% | TRIM −8% |
| 28 | CBIOCRESCENT BIOPHARMA INC. | 153,191 | $3M | 1.7% | NEW |
| 29 | RLAYRELAY THERAPEUTICS INC | 278,302 | $3M | 1.6% | NEW |
| 30 | MAZEMAZE THERAPEUTICS INC | 88,510 | $3M | 1.6% | NEW |
| 31 | CTMXCYTOMX THERAPEUTICS INC. | 521,468 | $2M | 1.4% | TRIM −30% |
| 32 | AVTXAVALO THERAPEUTICS INC | 159,341 | $2M | 1.4% | NEW |
| 33 | GKOSGLAUKOS CORP | 20,874 | $2M | 1.3% | TRIM −34% |
| 34 | CRBPCORBUS PHARMACEUTICALS HLDGS | 234,136 | $2M | 1.3% | ADD 68% |
| 35 | PENPENUMBRA INC | 6,300 | $2M | 1.2% | TRIM −30% |
| 36 | SOLENO THERAPEUTICS INC | 61,673 | $2M | 1.2% | NEW |
| 37 | LQDALIQUIDIA CORPORATION | 45,796 | $2M | 1.0% | TRIM −50% |
| 38 | ZBIOZENAS BIOPHARMA INC | 80,730 | $2M | 0.9% | NEW |
| 39 | NBPNOVABRIDGE BIOSCIENCES | 576,960 | $1M | 0.8% | ADD 15% |
| 40 | FDMT4D MOLECULAR THERAPEUTICS IN | 130,564 | $1M | 0.7% | NEW |
| 41 | NXTCNEXTCURE INC | 115,500 | $1M | 0.7% | TRIM −30% |
| 42 | PALIPALISADE BIO INC | 600,000 | $1M | 0.6% | TRIM −21% |
| 43 | ESTAESTABLISHMENT LABS HLDGS INC | 13,100 | $743,818 | 0.4% | HOLD |
| 44 | LPCNLIPOCINE INC NEW | 60,861 | $486,279 | 0.3% | NEW |
| 45 | ABUSARBUTUS BIOPHARMA CORP | 75,484 | $339,678 | 0.2% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| PRAXPRAXIS PRECISION MEDICINES I | — | — | 59K | 102K | 58K | 45K | $15M |
| COGTCOGENT BIOSCIENCES INC | — | 622K | 534K | 444K | 306K | 279K | $11M |
| ELVNENLIVEN THERAPEUTICS INC | — | — | — | — | 222K | 220K | $9M |
| IONSIONIS PHARMACEUTICALS INC | 61K | 136K | 121K | 131K | 117K | 110K | $8M |
| GHGUARDANT HEALTH INC | 148K | 127K | 98K | 98K | 98K | 83K | $8M |
| CYTKCYTOKINETICS INC | 66K | 103K | 116K | 142K | 125K | 104K | $7M |
| LLYELI LILLY & CO | 8K | 5K | 5K | 8K | 8K | 7K | $6M |
| ALMSALUMIS INC | — | — | — | 293K | 292K | 279K | $6M |
| BBIOBRIDGEBIO PHARMA INC | 247K | 165K | 156K | 133K | 81K | 67K | $5M |
| VERAVERA THERAPEUTICS INC | — | — | 77K | 156K | 124K | 115K | $5M |
| INSMINSMED INC | — | — | — | — | — | 27K | $4M |
| ELVELEVANCE HEALTH INC FORMERLY | — | — | — | — | 17K | 15K | $4M |
| AGIOAGIOS PHARMACEUTICALS INC | — | — | — | — | 137K | 125K | $4M |
| UTHRUnited Therapeutics Corp. | — | — | — | 7K | 8K | 7K | $4M |
| MLTXMOONLAKE IMMUNOTHERAPEUTICS | — | — | — | 178K | — | 215K | $4M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
